Research Trial articles, blogs, webinars, videos, fact sheets, resources, etc.
Breakthroughs and Discoveries 2017
The Basser Center's annual Breakthroughs & Discoveries panel brought together experts in the field of BRCA gene mutations: moderator Basser Executive Director Susan Domchek, MD, and panelists Steven Narod, MD, FRCPC, FRSC, Basser's Roger Greenberg, MD, PhD, Lewis Cantley, PhD, and Mark Robson, MD.
2018 Basser Center Global Prize Presentation
During the Sixth Annual Basser Center Scientific Symposium, the 2017 Basser Global Prize was presented to Ashok Venkitaraman, MBBS, PhD, the Ursula Zoellner Professor of Cancer Research and director of the Medical Research Council (MRC) Cancer Unit at the University of Cambridge.
Breakthroughs and Discoveries 2019
On Tuesday, May 7, 2019, the Basser Center presented a panel with internationally renowned BRCA experts on the latest in BRCA-related clinical research and patient care. This event was held during the Basser Scientific Symposium and is geared toward the general public.
Penn Center for Genome Integrity: Hereditary Cancer and Beyond
Roger Greenberg, MD, PhD, the Basser Center’s Director of Basic Science and the Director of the new Penn Center for Genome Integrity, discusses the new Center and how its research will apply to hereditary cancer and more.
BRCA and Pancreatic Cancer: Recent Advancements
Kim Reiss Binder, MD, a medical oncologist and clinical researcher with the Basser Center and the University of Pennsylvania, explains ongoing trials and recent advancements related to BRCA-related pancreatic cancer.
Genetic Testing Can Save Lives: Dr. Susan Domchek Discusses the BFOR Study
Basser Center Executive Director Susan Domchek, MD, discusses the BFOR Study and the importance of genetic testing for hereditary cancer in the Ashkenazi Jewish community.
Ask Dr. Domchek: Recent Treatment Options for BRCA-Related Cancers
In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.
2018 Breakthroughs and Discoveries Panel
The Basser Center's 2018 Breakthroughs and Discoveries Panel brought together some of the world's leading experts in genetic research and hereditary cancer.
The BRCA Founder Outreach Study (BFOR) Launches in Four Cities
The Basser Center's internationally recognized experts in cancer genetics, Susan Domchek, MD, and Katherine Nathanson, MD, are working in collaboration with leading experts in the fields of cancer research and genetics in New York, Los Angeles, and Boston to launch the pilot phase of a new, independent research initiative: the BRCA Founder Outreach (BFOR) Study.
New PARP Inhibitor Trial for BRCA1/2 and PALB2-Related Pancreatic Cancer
A phase II clinical trial that began in August of 2017, “A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation,” is enrolling patients at the Hospital of the University of Pennsylvania.